Novel SCN5A p.V1429M Variant Segregation in a Family with Brugada Syndrome
Open Access
- 16 August 2020
- journal article
- case report
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (16), 5902
- https://doi.org/10.3390/ijms21165902
Abstract
Brugada syndrome (BrS) is diagnosed by the presence of an elevated ST-segment and can result in sudden cardiac death. The most commonly found mutated gene is SCN5A, which some argue is the only gene that has been definitively confirmed to cause BrS, while the potential causative effect of other genes is still under debate. While the issue of BrS genetics is currently a hot topic, current knowledge is not able to result in molecular confirmation of over half of BrS cases. Therefore, it is difficult to develop research models with wide potential. Instead, the clinical genetics first need to be better understood. In this study, we provide crucial human data on the novel heterozygous variant NM_198056.2:c.4285G>A (p.Val1429Met) in the SCN5A gene, and demonstrate its segregation with BrS, suggesting a pathogenic effect. These results provide the first disease association with this variant and are crucial clinical data to communicate to basic scientists, who could perform functional studies to better understand the molecular effects of this clinically-relevant variant in BrS.This publication has 35 references indexed in Scilit:
- Programmed Ventricular Stimulation for Risk Stratification in the Brugada SyndromeCirculation, 2016
- High-throughput genetic characterization of a cohort of Brugada syndrome patientsHuman Molecular Genetics, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Nav1.5 mutations linked to dilated cardiomyopathy phenotypesChannels, 2013
- Risk Stratification in Brugada Syndrome: Results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) RegistryJournal of the American College of Cardiology, 2012
- Prevention of Ventricular Fibrillation Episodes in Brugada Syndrome by Catheter Ablation Over the Anterior Right Ventricular Outflow Tract EpicardiumCirculation, 2011
- KCNE5 Variants Are Novel Modulators of Brugada Syndrome and Idiopathic Ventricular FibrillationJournal of Arrhythmia, 2011
- An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testingHeart Rhythm, 2010
- A trafficking defective, Brugada syndrome-causing SCN5A mutation rescued by drugsCardiovascular Research, 2004
- Na+ channel mutation leading to loss of function and non-progressive cardiac conduction defectsJournal of Molecular and Cellular Cardiology, 2003